Ratopati English

आषाढ २०७८

AstraZeneca vaccine for people above 65 as second dose of Covishield

KATHMANDU, August 9: The Ministry of Health and Population has launched the AstraZeneca vaccination drive targeting the senior citizens above 65 years of age who have received the first dose of Covishield vaccine. The two-day vaccination campaign kicked off today. According to Ministry's joint-spokesperson Dr Samir Kumar Adhikari, the campaign was launched following the arrival of AstraZeneca vaccines from Bhutan and Japan. Covishield and AstraZeneca vaccine are developed by the same company and based on the same formula, with different brand names. It makes no difference for those already getting the first jab of Covishield to receive the AstraZeneca as the second dose. Senior citizens receiving the first dose of Covishield are to get the second dose after around four and half months of receiving the first dose. Some 1.4 million people above 65 years of age were given the first dose of Covishield from March 7 to 24. The second dose was delayed as vaccine purchased from India was not supplied. The vaccine is available from 149 vaccination centres in the capital.

पूर्ण विवरण

सम्बन्धित सामग्री

Poorer nations shun AstraZeneca Covid vaccine: Document

For the six months, poorer nations asked for only around half a million doses of the AstraZeneca Covishield vaccine produced by the Serum Institute of India, which COVAX had initially regarded as its main supplier.

The Kathmandu Post फाल्गुन २०७८

Govt to give Covishield & AstraZeneca for first dose

Citizens who are to receive their first dose of COVID vaccine will only be vaccinated with Covishield and AstraZeneca.

Nepalnews पौष २०७८

725,000 doses of Covishield vaccine arrive

Nepal has received additional 725,000 doses of Covishield, the AstraZeneca type vaccine manufactured by the Serum institute of India, from the COVAX facility. It is a part of the 6 million doses of the vaccine committed to be provided through the COVAX facility supported by the United Nations. “We have received 725,550 doses of Covishield from COVAX facility,” said Upendra Dhungana, chief of Logistic Management Section under the Department of Health Services. The second consignment of the vaccine with 972,000 doses will arrive soon, added Dhungana.

The Rising Nepal कार्तिक २०७८

Doctors clear confusion regarding effectiveness of AstraZeneca vaccine

With the beginning of the government’s AstraZeneca vaccination campaign from Monday, the senior citizens’ long wait to get the second dose of the COVID-19 vaccine has finally come to an end. However, as those who got the first dose of the Covishield vaccine in March had to wait for over five months to receive the second jab, many are questioning the efficacy of the AstraZeneca vaccine. Likewise, as the government is now distributing AstraZeneca as the second dose of Covishield many have a misconception that the vaccines are different from each other.

The Rising Nepal आषाढ २०७८

AstraZeneca vaccine for people above 65 as second dose of Covishield

The Ministry of Health and Population has launched the AstraZeneca vaccination drive targeting the senior citizens above 65 years of age who have received the first dose of Covishield vaccine.

The Rising Nepal आषाढ २०७८

300 thousand doses of AstraZeneca vaccines arrives from Japan

KATHMANDU, August 8: Additional 300 thousand doses of AstraZeneca vaccine provided by Japan to Nepal on grant arrived in Kathmandu today. According to the Secretary at the Ministry of Health and Population, Dr Roshan Pokhrel, on Saturday, Nepal had received 500 thousand doses of vaccines from Japan which has announced to gift 1.6 million doses of COVID-19 vaccine under the COVAX facility. The remaining doses of vaccine will be arriving after a week. It may be noted that on Friday, Nepal had received 230 thousand doses of Covishield vaccine from Bhutan. The COVID-19 vaccines received from Japan will be administered to those citizens who have got the first dose of Covishield. To date, around 10 million doses of vaccines (gifted and purchased) have arrived in the country. Nepal has bought four million doses of China-manufactured Vero Cell and two million doses of Covishield from India. But, one million doses of vaccine is yet to be supplied from India. Similarly, 1.1 million doses of Covishield have been obtained from India on grant and China has so far gifted 1.8 million doses of Vero Cell to Nepal. Likewise, Nepal had received 348 thousand doses of Covishield under the GAVI facility and 1.53 million doses of Janssen & Janssen vaccines from the United States of America in gift. With the regular supplies of vaccines, the government had added COVID-19 vaccination centers. Now the number of such centers stands at 4,422 against 2,989 of the earlier. The Kathmandu Valley alone has 149 vaccinations centers against 83 of the past.

Ratopati English आषाढ २०७८

Japan to provide AstraZeneca vaccines that could be used for waiting 65+ group

A ray of hope for senior citizens above 65 years of age who are waiting for the second dose of the Covishield Covid-19 vaccine for the past few months--Japan is providing some AstraZeneca vaccines to various Asian countries including Nepal.

Onlinekhabar English जेष्ठ २०७८

AstraZeneca vaccine to be provided as alternative to Covishield

The government is to provide the AstraZeneca COVID-19 vaccine as an alternative to the booster dose of Covishield vaccine.

The Himalayan Times बैशाख २०७८

AstraZeneca vaccine to be administered as alternative to Covishield

KATHMANDU, June 7: The government is preparing to administer the AstraZeneca COVID-19 vaccine as an alternative to the booster dose the Covishield vaccine. The government ‘s decision comes after the Serum Institute of India, the manufacturing company of Covishield vaccine and the COVAX Facility expressed inability to supply additional quantities of Covishield vaccines to Nepal for the time being. The Ministry of Health and Population (MOHP) is planning to administer the AstraZeneca vaccine for those waiting for the booster shot of Covishield as both vaccines are similar in nature and composition. Director of Family Welfare Division, Department of Health Services, Dr Taranath Pokhrel said that AstraZeneca will be provided to those receiving the first jab of Covishield as both vaccines were developed by the same company being based on the same formula and methodology and it would make no difference in giving the AstraZeneca as an alternative to the Covishield. The vaccination schedule is yet to be fixed. The booster or second dose is to be taken after 12-16 weeks of getting the first shot. \Around 1.4 million people above 65 years of age were provided the first shot of Covishield from 7th March to 23rd March. They are waiting for the final shot as the Serum Institute of India expressed its inability to supply one million doses of vaccines that Nepal had procured from the company for the time being in view of the increasing infections rate in India. So far in Nepal, the number of the population receiving the first shot of COVID-19 jab stands at 2.13 million while 691,184 have received the full course. The government is administering the China –manufactured Vero Cell to the people from 60-64 age group from tomorrow, Tuesday.

Ratopati English बैशाख २०७८

AstraZeneca vaccine to be provided as alternative to Covishield

KATHMANDU, June 7: The government has decided to provide the AstraZeneca COVID-19 vaccine as an alternative to the booster dose of the Covishield vaccine.

Republica बैशाख २०७८